Concepedia

Apurva Patel

AP

Statistics

Publications

22

Citations

983

H-Index

15

Active since

1999

Affiliations

Gujarat Cancer & Research Institute(Current)

Government Medical College

The University of Texas MD Anderson Cancer Center

Fondazione IRCCS Istituto Nazionale dei Tumori

Chinese PLA General Hospital

Apurva Patel is an author at Gujarat Cancer & Research Institute specializing in medicine, oncology, and chemotherapy.

ORCID

Publications per year

1999–2024

22

Publications

22

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

Yuichiro� Doki, Jaffer A. Ajani, Ken Kato et al. · UCL Discovery (University College London) · 2022 · 532 citations · Full text

, , +17

Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (<scp>CheckMate</scp> 648): 29‐month follow‐up from a randomized, open‐label, phase <scp>III</scp> trial

Ken Kato, Yuichiro� Doki, Ian Chau et al. · Cancer Medicine · 2024 · 51 citations · Full text

, , +14

A Study of Use of “PORT” Catheter in Patients with Cancer: A Single-Center Experience

Irappa Madabhavi, Apurva Patel, Malay Sarkar et al. · Clinical Medicine Insights Oncology · 2017 · 38 citations · Full text

, , +12

Phase 1 Study Update of the Novel Pan-Pim Kinase Inhibitor LGH447 in Patients with Relapsed/ Refractory Multiple Myeloma

Marc S. Raab, Enrique M. Ocio, Sheeba K. Thomas et al. · Blood · 2014 · 31 citations

, , +11

Safety and Efficacy of Eltrombopag in Post-hematopoietic Stem Cell Transplantation (HSCT) Thrombocytopenia

Shreeniwas S. Raut, Sandip Shah, Vijay V. Sharanangat et al. · Indian Journal of Hematology and Blood Transfusion · 2014 · 30 citations · Full text

, , +12

1–5 of 22